[Dysplasia in Barrett's esophagus--intra- and interobserver variability in histopathological diagnosis].

BACKGROUND Barrett's esophagus is a well-known pre-malignant condition. Pathologic interpretation of biopsy specimens guides endoscopic surveillance as well as the therapeutic approach that will be carried out. However, the predictive value of histopathologic diagnosis can be questioned due to its poor intra- and interobserver reproducibility. AIMS To assess intra- and interobserver variability in the diagnosis of Barrett's dysplasia. MATERIAL AND METHODS Three-micrometer thick sections from biopsy specimens from 42 patients with Barrett's esophagus were stained with hematoxylin-eosin and PAS-alcian blue. The reading of the slides was carried out blindly in a light microscope. Intra and interobserver variability in the interpretation of the slides was determined by kappa statistics. RESULTS The number of tissue specimens was 229, with average of 5.45 (1 to 18) fragments for patient. Low grade dysplasia was diagnosed by pathologists in 21.4% to 52.4% of the cases. The intra-observer agreement for the diagnosis of low grade dysplasia was slight (kappa = 0.30). The interobserver agreement for the diagnosis of low grade dysplasia was poor, with kappa scores between 0.05 and 0.16. The diagnosis of dysplasia, with agreement for all pathologists examining the same set of slides, was 14.3%. CONCLUSIONS Pathologic interpretation of Barrett's dysplasia may be subject to marked intra- and interobserver variabiliaty. Interpretation of low grade dysplasia, as high grade dysplasia, should also be considered for review by two or more pathologists.

[1]  J. Goldblum,et al.  p53 expression in low grade dysplasia in Barrett’s esophagus: correlation with interobserver agreement and disease progression , 2002 .

[2]  M. Sivak,et al.  Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. , 2001, Endoscopy.

[3]  B. Reid,et al.  Biomarkers in Barrett esophagus. , 2001, Mayo Clinic proceedings.

[4]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[5]  B. Wijnhoven,et al.  Molecular Biology of Barrett’s Adenocarcinoma , 2001, Annals of surgery.

[6]  L. Burgart,et al.  Endoscopic and histologic diagnosis of Barrett esophagus. , 2001, Mayo Clinic proceedings.

[7]  J. Goldblum,et al.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression , 2000, American Journal of Gastroenterology.

[8]  P. van Eyken,et al.  The diagnosis of dysplasia and malignancy in Barrett's oesophagus , 2000, Histopathology.

[9]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[10]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[11]  A. Stewart,et al.  Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. , 2000, Journal of the American College of Surgeons.

[12]  T. Demeester,et al.  Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. , 2000, Annals of surgery.

[13]  A. Weston,et al.  Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma , 1999, American Journal of Gastroenterology.

[14]  G. Falk,et al.  The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999, American Journal of Gastroenterology.

[15]  R. Sampliner,et al.  Barrett's esophagus: update on screening, surveillance, and treatment. , 1999, Archives of internal medicine.

[16]  O. Cummings,et al.  Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. , 1999, Gastrointestinal endoscopy.

[17]  D. Katzka,et al.  Barrett's esophagus: continuing questions and controversy. , 1999, Gastrointestinal endoscopy.

[18]  M. Canto Vital staining and Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[19]  C. Ortiz-Hidalgo,et al.  The histopathology and biologic prognostic factors of Barrett's esophagus: a review. , 1998, Journal of clinical gastroenterology.

[20]  A. Cameron Management of Barrett's esophagus. , 1998, Mayo Clinic proceedings.

[21]  A. Schned,et al.  The Development of Dysplasia and Adenocarcinoma During Endoscopic Surveillance of Barrett’s Esophagus , 1998 .

[22]  A. Cameron,et al.  Epidemiology of columnar-lined esophagus and adenocarcinoma. , 1997, Gastroenterology clinics of North America.

[23]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.